CIK 0001637715
- Emerging growth company
OnKure Therapeutics, Inc.
Sign in to watch- Ticker
- OKUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472309515
- Phone
- +1 720-307-2892
- Business address
- 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
- Former names
- Reneo Pharmaceuticals, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 86 shares at $4.16 ($357)
- 4 Open-market sale Chief Financial Officer sold 301 shares at $4.16 ($1,251)
- 4 Grant or award Director acquired 3,911 shares (grant or award)
- 4 Grant or award Director acquired 5,258 shares (grant or award)
- 4 Open-market sale President and CEO sold 87 shares at $2.97 ($258)
- 4 Open-market sale Chief Financial Officer sold 302 shares at $2.97 ($896)
- 4 Grant or award Director acquired 4,125 shares (grant or award)
- 4 Grant or award Director acquired 5,545 shares (grant or award)
- 4 Open-market sale President and CEO sold 88 shares at $2.62 ($231)
- 4 Open-market sale Chief Financial Officer sold 303 shares at $2.62 ($795)
- 4 Grant or award Director acquired 4,694 shares (grant or award)
Page 2 of 9 · 171 filings